Shin Nippon Biomedical Laboratories, Ltd.'s total assets for Q1 2025 were ¥89.07B, a decrease of -3.62% from the previous quarter. JP:2395 total liabilities were ¥53.17B for the fiscal quarter, a 1.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Total Assets
¥ 105.06B
¥ 92.42B
¥ 76.30B
¥ 58.31B
¥ 39.38B
Total Liabilities
¥ 61.57B
¥ 52.33B
¥ 42.14B
¥ 31.95B
¥ 19.66B
Total Equity Gross Minority
¥ 43.49B
¥ 40.09B
¥ 34.16B
¥ 26.36B
¥ 19.72B
Other Metrics
Currency in JPY
Shin Nippon Biomedical Laboratories, Ltd. Debt to Assets